0000867840
false
--06-30
0000867840
2022-10-27
2022-10-27
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported)
October 27, 2022
PRECISION
OPTICS CORPORATION, INC.
(Exact name of registrant as specified in its charter)
| Massachusetts |
|
001-10647 |
|
04-2795294 |
| (State or other jurisdiction |
|
(Commission |
|
(IRS Employer |
| of incorporation) |
|
File Number) |
|
Identification No.) |
| |
|
|
|
|
22
East Broadway,
Gardner,
Massachusetts |
|
01440 |
| (Address of principal executive offices) |
|
(Zip Code) |
(Registrant’s telephone number, including
area code) (978) 630-1800
N/A
(Former name or former address, if changed since
last report)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction
A.2. below):
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to
Section 12(b) of the Act: None
Securities registered pursuant to
Section 12(g) of the Act:
| Title of each class |
|
Trading symbol(s) |
|
Name of each exchange on which registered |
| Common stock, $0.01 par value |
|
PEYE |
|
OTCQB |
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange
Act of 1934 (17 CFR §240.12b-2).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant
to Section 13(a) of the Exchange Act. ☐
Item 3.03 Material
Modification to Rights of Security Holders.
To the extent required
by Item 3.03 of Form 8-K, the information contained in Item 5.03 of this Current Report on Form 8-K is incorporated herein by reference.
Item 5.03 Amendments
to Articles of Incorporation or Bylaws; Change in Fiscal Year.
As previously reported,
at the Annual Meeting of Shareholders of Precision Optics Corporation, Inc. (the “Company”) held on April 8, 2022, stockholders
holding more than a majority of the outstanding shares of Common Stock approved a proposed amendment to the Articles of Organization authorizing
the Board of Directors (the “Board”) to effect a reverse stock split of the Common Stock at a ratio to be determined by the
Board within a stated range of 1:1.5 to 1:3.
On the basis of such
approval, the Board decided to proceed with the reverse split at a ratio of 1:3 (the “Reverse Stock Split”). The Company filed
Articles of Amendment with the Secretary of the Commonwealth of Massachusetts on October 24, 2022. Under that filing, the Reverse Stock
Split was to become effective after the close of business on Wednesday, October 26, 2022. Due to unanticipated delays in obtaining necessary
trading clearances, however, the Company on October 26, 2022 made a further Articles of Amendment filing with the Secretary of the Commonwealth
to override the earlier amendment and thus avoid the reverse split taking effect later that day.
Having received appropriate
indications on October 27, 2022 that the necessary trading clearances would be forthcoming, the Company then set a new effective date
of the Reverse Stock Split for 11:59 p.m. Eastern Time on Tuesday, November 1, 2022 (the “Revised Effective Time”) and filed
additional Articles of Amendment with the Secretary of the Commonwealth accordingly on October 27, 2022.
As a result of the Reverse
Stock Split, every three shares of issued and outstanding Common Stock at the Revised Effective Time were automatically combined into
one issued and outstanding share of Common Stock, without any change in the par value per share. No fractional shares were issued as a
result of the Reverse Stock Split. Stockholders that would have otherwise received fractional shares will receive cash in lieu of the
fractional shares at the average closing price per share of the Common Stock as reported for the last five trading days before the Reverse
Stock Split became effective. The Reverse Stock Split reduces the number of shares of Common Stock outstanding from 16,915,089 shares
to approximately 5,638,302 shares, after reduction for the elimination of fractional shares. The total number of shares of Common Stock
authorized under the Articles of Organization remains unchanged, at 50,000,000 shares.
Proportionate adjustments
will be made to the per share exercise price and the number of shares that may be purchased upon exercise of outstanding stock options
previously granted by the Company, and to the number of shares of Common Stock reserved for future issuance under the Company’s
existing 2011, 2021, and 2022 Equity Incentive Plans.
The Common Stock began
trading on a reverse stock split-adjusted basis on the OTCQB on November 2, 2022, that being the day after the Revised Effective Time.
The new CUSIP number for the Common Stock following the Reverse Stock Split is: 740294400.
The information set forth
herein is qualified in its entirety by reference to the complete text of the described Articles of Amendment, copies of which are filed
with this report as Exhibits 3.1 and 3.2.
Item 9.01 Financial Statements and
Exhibits.
(d) Exhibits
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| |
PRECISION OPTICS CORPORATION, INC. |
| |
|
| |
|
| |
|
| Date: November 2,
2022 |
By: |
/s/ Daniel
S. Habhegger |
| |
|
Name: Daniel S. Habhegger
Title: Secretary |
Exhibit 3.1
MA SOC Filing Number: 202249772830 Amber Orman POTSmodem4 Date: 10/24/2022 8:35:00 AM (2/5) 10/24/2022 08:32:20 AM - 0400 D PC The Commonwealth of Massachusetts William Francis Galvin Secretary of the Commonwealth One Ashburton Place, Boston, Massachusetts 02108 - 1512 Articles of Amendment (General Laws Chapter 156D, Section 10.06; 950 CMR 113.34) (1) Exacc name of corporacion: Pre c _ i s _ i o _ _ n _ O _ p t _ i c _ s _ C _ o r p _ o _ r _ a t i _ _ o _ n , _ l n _ c _ . _ (2) Regiscered office address: 22 East Broadway, Gardner, MA 01440 (number, street, city or town, state, zip code) (3) These art icl es of amendmenc affecc arc i cl e(s): _ 1 1 _ 1 _ (specify the number(s) of article(s) being amended (I - VI )) (4) Dace ado p ced: October 14 , 2022 (m onth, day, year) (5) Approved by: (check appropriate box) D ch e incor poracor s . D ch e bo ard of directors wichouc s h areho lder app rova l and shareh o lder app rova l was not required. 0 the bo ard of directors and the shareho ld ers in the manner required by l aw and the artic l es of organization. (6) Scace che artic le number and che ce xc of che amend ment . Unless contained in che cexc of che amendment, scare che provisions for implemencing che exchange, reclassification or cance ll at i on of i ssued shares . Article Ill of the Corporation's Articles of Organization , as amended, is amended hereby by inserting the following: " As of 11:59 p.m . Eastern Time on Wednesday, October 26, 2022 (the "Effective Time"), each three (3) issued and outstanding shares of authorized Common Stock of the Corporation, $0.01 par value per share, shall be reclassified and combined into one (1) share of Common Stock. There shall be no fractional shares issued. Each resulting fractional share shall be entitled to receive cash for the value of the fraction. The total number of authorized shares of Common Stock immediately after the Effective Time shall continue to be 50,000,000."
Amber Orman POTSmodem4 (3/5) 10 / 24 /2022 08:33:00 AM - 0400 To change th e number of shares and the par va lu e , * if any , of any type, or to designate a class o r series , of stock, or c h ange a d es i g n a ti on of d;:iss or ser i es of stock, wh ic h rhe cor porn rio n i s ;:imhori7.ecl to i s su e, rn mp l ere rh e following: T ota l a utho ri zed pr ior co amendment: WITHOUT PAR VALUE WITH PAR VALUE TYPE NUMBER OF SHARES TYPE NUMBER OF S HARE S PAR VALUE Common 50,000,000 $0.01 Total authorized after amendment : WITHOUT PAR VALUE WITH PAR VALUE TYPE NUMBER OF S HARES T Y PE NUMBER O F SHARES PAR VALUE Common 50,000,000 $0.01 (7) Th e amendment sha ll b e e ff ec tive at th e tim e an d on th e dat e approved by ch e Division , unl ess a l acer e ff ec ti ve dat e noc mor e chan 90 days from che dace and tim e of filing is specified:
Amber Orman POTSmodem4 ( 4 / 5) 10 / 24 / 2022 08:33:29 AM - 04 0 0 \ , ' , ' \ ( '. \ , . . · f , . / · ) / ·" · . / (itgw,tu rc o f 1wthanud u ulin . du1,1/1 'i / [J C h .Ji n · 1an o f' t h cj oa rd of 1 F 1 ( > r s, [] PiT , idcm , _,,/' (_. - , [?J O d1tT o ffice , r [J c:o u n - - appo i n ti : d fid u ci ar y',
MA SOC Filing Number: 202249772830 Date: 10/24/2022 8:35:00 AM THE COMMONWEALTH OF MASSACHUSETTS I hereby certify that, upon examination of this document, duly submitted to me, it appears that the provisions of the General Laws relative to corporations have been complied with, and I hereby approve said articles; and the filing fee having been paid, said articles are deemed to have been filed with me on: October 24, 2022 08:35 AM WILLIAM FRANCIS GALVIN Secretary of the Commonwealth
MA SOC Filing Number: 202250996520 Date: 10/26/2022 4:56:00 PM
Nick Anania POTSmodem4 (3/5) 10/26/2022 04:54:57 PM - 0400 TO change the number of shares and the par value, "' if any, of any type, or to designate a class or series, of stock or change a designation of class or series of stock, which the corporation is aurhorized to issue, complete the following: TOral authorized prior to amendment: WITHOUT PAR VALUE WITH PAR VALUE TYPE NUMBER 01' SHARES TYPE NUMBER 01' SHARES PAR VALUE Common 50,000,000 $0.01 Total authorized after amendment: WITHOlff PAR VALUE WITH PAR VALUE TYPE NUMBER OF SHARES TYPE NUMBER OF SHARES PAR VALUE Common 50,000,000 $0.01 (7) 1he amendment shall be d1ecrivc at the time and on the date approved by the Division, unless a later dlCcrivc dare nor more than 90 days from rhe dare and rime of filing is specified: ................................................................................................................. ''G.L. C'hapta 156D dimint1tes the mnttf.>t ofj.>t1t valul', hoWl'Vr!t rz tmpomtirm mrzy spl't{/y JMr va!ut' in .Artidl' Ill. 5i'et c;.L. Chr:pit'I" 156D, ,5cttion 6.21, and the co,nments rcbtive thereto.
Nick Anania POTSmodem4 Cl [J [2]i Od1u 11rlll'.1:1 [] Co1.11·t· ,1ppurn1.,.d !'Ill tl,J, .klJ >J........................................ (4/5) 10/26/2022 04:55:27 PM - 0400
THE COMMONWEALTH OF MASSACHUSETTS WILLIAM FRANCIS GALVIN Secretary of the Commonwealth I hereby certify that, upon examination of this document, duly submitted to me, it appears that the provisions of the General Laws relative to corporations have been complied with, and I hereby approve said articles; and the filing fee having been paid, said articles are deemed to have been filed with me on: October 26, 2022 04:56 PM MA SOC Filing Number: 202250996520 Date: 10/26/2022 4:56:00 PM
Exhibit 3.2
MA SOC Filing Number: 202250824120 Date: 10/27/2022 4:21:00 PM
Nick Anania POTSmodem4 (3/5) 10/27/2022 04:18:39 PM - 0400 TO change the number of shares and the par value,+ if any, of any type, or to designate a class or series, of stock, or change a designation of class or series of stock, which the corporation is authorized rn issue, complete the following: TOral authorized prior to amendment: WITHOUT PAR VALUE WITH PAR VALUE TYPE N UMBJcR 01' SHARJcS TYPE N UMBJcR 01' SHARJcS PAR VALUJc Common 50,000,000 $0.01 Total authorized after amendment: WITHOlff PAR VALUE WITH PAR VALUE TYPE NUMBER OF SHARES TYPE NUMBER OF SHARES PAR VALUE Common 50,000,000 $0.01 (7) 1he amendment shall be effCcrive at the time and on the dare approved by the Division, unless a later effCcrive date not more than ()O days from the dare and rime of filing is specified: (/Jtij)tl'r 156D, ''G.L. C'hapta 156D dirnint1tes the mntl'j.>t ofpat valul', hon'l'Vf:'t d m17)()mtirm mrzy JjH'tifJ pat v11!ul' in .Attidt !ff. 5i'tt' G.L ,5cttion 621, tmd the co,nments rcbtive thereto.
Nick Anania POTSmodem4 ( 4/5 ) 10/27/2022 04:19:13 PM - 0400 (signature ofauthorized individual} D D 0 Other officer, D Court - appointed fiduciary, on this _.2.,1.,..th, day of October , 2022
THE COMMONWEALTH OF MASSACHUSETTS WILLIAM FRANCIS GALVIN Secretary of the Commonwealth I hereby certify that, upon examination of this document, duly submitted to me, it appears that the provisions of the General Laws relative to corporations have been complied with, and I hereby approve said articles; and the filing fee having been paid, said articles are deemed to have been filed with me on: October 27, 2022 04:21 PM MA SOC Filing Number: 202250824120 Date: 10/27/2022 4:21:00 PM
Exhibit 99.1
 |
PRECISION
OPTICS CORPORATION
22 EAST BROADWAY
GARDNER, MASSACHUSETTS 01440-3338
Telephone 978 / 630-1800
Telefax 978 / 630-1487
|
POC22-0108
Precision Optics
Announces Implementation of 1-for-3 Reverse Stock Split in
Preparation for Planned Uplisting to Nasdaq
GARDNER, MA, October 26, 2022. Precision Optics
Corporation, Inc. (OTCQB: PEYE) (the “Company”) announced today that it will affect a 1-for-3 reverse split of its common
stock in preparation for the planned listing of the common stock on The Nasdaq Stock Market (“Nasdaq”). The reverse stock
split is scheduled to become effective after the close of business on Wednesday, October 26, 2022 (the “Effective Time”).
The stock is then expected to begin trading on a split-adjusted basis when the market opens on October 27, 2022, under the temporary ticker
symbol “PEYED” pending completion of the listing on Nasdaq. Once the listing on Nasdaq occurs, the trading symbol for the
shares will change to “POCI.”
The Company has filed its listing application
with Nasdaq and believes it presently satisfies all applicable listing requirements other than the minimum share price condition. The
reverse stock split is intended to enable the Company to meet that condition. Provided that the closing stock price for 5 consecutive
trading days after the reverse stock split is at least $3.00 and provided that the 30-day split-adjusted average daily volume is at least
2,000 shares, the Company expects the listing of its shares on Nasdaq will occur in the first or second week of November 2022.
As a result of the reverse stock split, every
3 outstanding shares of common stock will be exchanged for 1 share of common stock, with any fractional shares being paid out by the Company
in cash. The reverse stock split will affect all stockholders uniformly and will not alter any stockholder’s percentage interest
in the Company’s equity, except to the extent that the reverse stock split would result in a stockholder owning a fractional share.
No fractional shares will be issued in connection with the reverse stock split. Stockholders who otherwise would be entitled to receive
a fractional share will instead be entitled to receive cash (rounded up to the nearest cent, without interest and subject to applicable
withholding taxes) in lieu of such fractional share from the Company’s transfer agent, Computershare Trust Company, N.A., in an
amount equal to the product obtained by multiplying (a) the average closing price per share of the Company’s common stock as reported
on OTCQB for the five trading days before the Effective Time, by (b) the number of shares of common stock outstanding at the Effective
Time that were converted into fractional shares. Holders of the Company’s common stock held in book-entry form or through a bank,
broker or other nominee do not need to take any action in connection with the reverse stock split. Stockholders of record will be receiving
information from the Company’s transfer agent regarding their post-split common stock ownership.
The reverse stock split will reduce the number
of shares of Company’s common stock outstanding from 16,915,089 shares to approximately 5,638,363 shares, subject to further reduction
for the elimination of fractional shares.
At the Company’s Annual Meeting of Shareholders
held on April 8, 2022, stockholders approved an amendment of the Articles of Organization to authorize a reverse stock split of the Company’s
common stock at a ratio in the range of 1:1.5 to 1:3. Pursuant to that authority, the Company’s board recently approved the 1:3
reverse stock split ratio.
About Precision Optics Corporation
Founded in 1982, Precision Optics is a vertically
integrated optics company primarily focused on leveraging its proprietary micro-optics and 3D imaging technologies to the healthcare and
defense/aerospace industries by providing services ranging from new product concept through mass manufacture. Utilizing its leading-edge
in-house design, prototype, regulatory and fabrication capabilities as well as its Lighthouse Imaging division’s electronic imaging
expertise and its Ross Optical division’s high volume world-wide sourcing, inspecting and production resources, the Company is able
to design and manufacture next-generation product solutions to the most challenging customer requirements. Within healthcare, Precision
Optics enables next generation medical device companies around the world to meet the increasing demands of the surgical community who
require more enhanced and smaller imaging systems for minimally invasive surgery as well as 3D endoscopy systems to support the rapid
proliferation of surgical robotic systems. In addition to these next generation applications, Precision Optics has supplied top tier medical
device companies a wide variety of optical products for decades, including complex endocouplers and specialized endoscopes. The Company
is also leveraging its technical proficiency in micro-optics to enable leading edge defense/aerospace applications which require the highest
quality standards and the optimization of size, weight and power. For more information,
please visit www.poci.com.
About Forward-Looking Statements
This press release contains forward-looking statements.
Forward-looking statements include, but are not limited to, statements that express the Company’s intentions, beliefs, expectations,
strategies, predictions or any other statements related to the Company’s future activities or future events or conditions. These
statements are based on current expectations, estimates and projections about the Company’s business based, in part, on assumptions
made by the Company’s management. These statements are not guarantees of future performances and involve risks, uncertainties and
assumptions that are difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed or forecasted
in the forward-looking statements due to numerous factors, including those risks discussed in the Company’s annual report on Form
10-K and in other documents that we file from time to time with the SEC. Any forward-looking statements speak only as of the date on which
they are made, and the Company does not undertake any obligation to update any forward-looking statement to reflect events or circumstances
after the date of this report, except as required by law.
Company Contact:
PRECISION OPTICS CORPORATION
22 East Broadway
Gardner, Massachusetts 01440-3338
Telephone: 978-630-1800
Investor Contact:
LYTHAM PARTNERS, LLC
Robert Blum
Phoenix | New York
Telephone: 602-889-9700
peye@lythampartners.com
Exhibit 99.2
|
PRECISION
OPTICS CORPORATION
22 EAST BROADWAY
GARDNER, MASSACHUSETTS 01440-3338
Telephone 978 / 630-1800
Telefax 978 / 630-1487
|
POC22-0110
Precision Optics
Announces Delay in Effective Date of Reverse Split
GARDNER, MA, October 27, 2022. Precision Optics
Corporation, Inc. (OTCQB: PEYE) (the “Company”) announced today that the Company is amending the date for its reverse stock
split, due to an unanticipated delay in obtaining necessary regulatory clearances. The Company expects to announce revised timing for
the reverse split in the near future.
Previously, the Company had planned for its reverse
split to become effective after the close of business on Wednesday, October 26, 2022, and had expected the common stock to begin trading
on a split-adjusted basis when the market opened the following day.
The reverse split of its common stock is related
to the Company’s application for listing of the common stock on The Nasdaq Stock Market (“Nasdaq”). The Company remains
committed to both the completion of the reverse split and the planned listing on Nasdaq.
About Precision Optics Corporation
Founded in 1982, Precision Optics is a vertically
integrated optics company primarily focused on leveraging its proprietary micro-optics and 3D imaging technologies to the healthcare and
defense/aerospace industries by providing services ranging from new product concept through mass manufacture. Utilizing its leading-edge
in-house design, prototype, regulatory and fabrication capabilities as well as its Lighthouse Imaging division’s electronic imaging
expertise and its Ross Optical division’s high volume world-wide sourcing, inspecting and production resources, the Company is able
to design and manufacture next-generation product solutions to the most challenging customer requirements. Within healthcare, Precision
Optics enables next generation medical device companies around the world to meet the increasing demands of the surgical community who
require more enhanced and smaller imaging systems for minimally invasive surgery as well as 3D endoscopy systems to support the rapid
proliferation of surgical robotic systems. In addition to these next generation applications, Precision Optics has supplied top tier medical
device companies a wide variety of optical products for decades, including complex endocouplers and specialized endoscopes. The Company
is also leveraging its technical proficiency in micro-optics to enable leading edge defense/aerospace applications which require the highest
quality standards and the optimization of size, weight and power. For more information,
please visit www.poci.com.
About Forward-Looking Statements
This press release contains forward-looking statements.
Forward-looking statements include, but are not limited to, statements that express the Company’s intentions, beliefs, expectations,
strategies, predictions or any other statements related to the Company’s future activities or future events or conditions. These
statements are based on current expectations, estimates and projections about the Company’s business based, in part, on assumptions
made by the Company’s management. These statements are not guarantees of future performances and involve risks, uncertainties and
assumptions that are difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed or forecasted
in the forward-looking statements due to numerous factors, including those risks discussed in the Company’s annual report on Form
10-K and in other documents that we file from time to time with the SEC. Any forward-looking statements speak only as of the date on which
they are made, and the Company does not undertake any obligation to update any forward-looking statement to reflect events or circumstances
after the date of this report, except as required by law.
Company Contact:
PRECISION OPTICS CORPORATION
22 East Broadway
Gardner, Massachusetts 01440-3338
Telephone: 978-630-1800
Investor Contact:
LYTHAM PARTNERS, LLC
Robert Blum
Phoenix | New York
Telephone: 602-889-9700
peye@lythampartners.com
Exhibit 99.3
|
PRECISION
OPTICS CORPORATION
22 EAST BROADWAY
GARDNER, MASSACHUSETTS 01440-3338
Telephone 978 / 630-1800
Telefax 978 / 630-1487
|
POC22-0114
Precision Optics
Announces Updated Implementation Date of 1-for-3 Reverse Stock Split in Preparation for Planned Uplisting to Nasdaq
GARDNER, MA, November 2, 2022. Precision Optics
Corporation, Inc. (OTCQB: PEYE) (the “Company”) announced today that the planned 1-for-3 reverse split of its common stock
became effective after the close of business on Tuesday, November 1, 2022 (the “Effective Time”). The stock will begin trading
on a split-adjusted basis when the market opens on November 2, 2022. Temporarily (for a maximum of 20 trading days), the ticker symbol
for the Company’s common stock will show as “PEYED” instead of PEYE.
The reverse stock split is expected to facilitate
the Company’s listing application with Nasdaq. Among other conditions, that listing requires that the Company’s closing stock
price for 5 consecutive trading days is at least $3.00 and that the 30-day split-adjusted average daily volume is at least 2,000 shares.
Subject to satisfying those conditions, Company management anticipates that the Nasdaq listing will likely occur in the coming weeks.
As a result of the reverse stock split, every
3 outstanding shares of common stock were exchanged for 1 share of common stock. No fractional shares are being issued in connection with
the reverse stock split. Stockholders who otherwise would be entitled to receive a fractional share will instead be entitled to receive
cash (computed at the 5-day average closing price, rounded up to the nearest cent), without interest and subject to applicable withholding
taxes. Those who hold Company common stock in book-entry form or through a bank, broker or other nominee do not need to take any action
in connection with the reverse stock split. Stockholders who hold of record will be receiving information about their shares from the
Company’s transfer agent, Computershare Trust Company, N.A.
The reverse stock split reduces the number of
shares of Company’s common stock outstanding from 16,915,089 shares to approximately 5,638,302 shares. The reverse stock split affects
all stockholders uniformly and does not alter any stockholder’s percentage interest in the Company’s equity, except for the
purchase of the holder’s fractional shares.
About Precision Optics Corporation
Founded in 1982, Precision Optics is a vertically
integrated optics company primarily focused on leveraging its proprietary micro-optics and 3D imaging technologies to the healthcare and
defense/aerospace industries by providing services ranging from new product concept through mass manufacture. Utilizing its leading-edge
in-house design, prototype, regulatory and fabrication capabilities as well as its Lighthouse Imaging division’s electronic imaging
expertise and its Ross Optical division’s high volume world-wide sourcing, inspecting and production resources, the Company is able
to design and manufacture next-generation product solutions to the most challenging customer requirements. Within healthcare, Precision
Optics enables next generation medical device companies around the world to meet the increasing demands of the surgical community who
require more enhanced and smaller imaging systems for minimally invasive surgery as well as 3D endoscopy systems to support the rapid
proliferation of surgical robotic systems. In addition to these next generation applications, Precision Optics has supplied top tier medical
device companies a wide variety of optical products for decades, including complex endocouplers and specialized endoscopes. The Company
is also leveraging its technical proficiency in micro-optics to enable leading edge defense/aerospace applications which require the highest
quality standards and the optimization of size, weight and power. For more information,
please visit www.poci.com.
About Forward-Looking Statements
This press release contains forward-looking statements.
Forward-looking statements include, but are not limited to, statements that express the Company’s intentions, beliefs, expectations,
strategies, predictions or any other statements related to the Company’s future activities or future events or conditions. These
statements are based on current expectations, estimates and projections about the Company’s business based, in part, on assumptions
made by the Company’s management. These statements are not guarantees of future performances and involve risks, uncertainties and
assumptions that are difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed or forecasted
in the forward-looking statements due to numerous factors, including those risks discussed in the Company’s annual report on Form
10-K and in other documents that we file from time to time with the SEC. Any forward-looking statements speak only as of the date on which
they are made, and the Company does not undertake any obligation to update any forward-looking statement to reflect events or circumstances
after the date of this report, except as required by law.
Company Contact:
PRECISION OPTICS CORPORATION
22 East Broadway
Gardner, Massachusetts 01440-3338
Telephone: 978-630-1800
Investor Contact:
LYTHAM PARTNERS, LLC
Robert Blum
Phoenix | New York
Telephone: 602-889-9700
peye@lythampartners.com